Insights

Platform Expansion Cytel recently launched East Horizon, a cloud based platform for collaborative clinical trial design and simulation. This creates potential sales opportunities for cloud infrastructure, data integration, cybersecurity, and user adoption solutions that can support its platform growth.

AI Partnerships Cytel is expanding AI and machine learning applications through partnerships with Nested Knowledge and Adial Pharmaceuticals. Vendors offering AI enablement, evidence management, analytics infrastructure, or regulatory compliant data workflows may find a relevant opening.

Trial Intelligence The Citeline partnership combines clinical trial intelligence with Cytel’s enrollment forecasting and feasibility capabilities. This focus on improving study planning could create demand for complementary data sources, forecasting tools, interoperability, and sponsor facing workflow solutions.

Leadership Transition CEO Jovan Willford is set to leave in November 2026, while Cytel has also promoted a clinical data management leader with major account P&L responsibility. Sales teams should track the executive transition and engage both new leadership and operational decision makers as priorities evolve.

Global Operations With more than 2,000 employees across North America, Europe, and Asia, Cytel operates at global scale and reports revenue of $500 million to $1 billion. Its use of SAP, SuccessFactors, GitLab, and Microsoft Sentinel suggests potential needs in enterprise integration, workforce systems, software delivery, and security.

Similar companies to Cytel

Cytel Tech Stack

Cytel uses 8 technology products and services including HubSpot Analytics, SAP SuccessFactors, Drupal, and more. Explore Cytel's tech stack below.

Media & News

Cytel's Email Address Formats

Cytel uses at least 4 email formats:
Cytel Email FormatsExamplePercentage
First.Last@cytel.comJohn.Doe@cytel.com
95%
First@cytel.comJohn@cytel.com
3%
First.Middle@cytel.comJohn.Michael@cytel.com
1%
FLast@cytel.comJDoe@cytel.com
1%

Frequently Asked Questions

What is Cytel's stock symbol?

Minus sign iconPlus sign icon
Cytel is a publicly traded company; the company's stock symbol is IDMI.

What is Cytel's official website and social media links?

Minus sign iconPlus sign icon
Cytel's official website is cytel.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Cytel generate?

Minus sign iconPlus sign icon
As of October 2026, Cytel's annual revenue is estimated to be $500M - $1B.

What is Cytel's NAICS code?

Minus sign iconPlus sign icon
Cytel's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Cytel have currently?

Minus sign iconPlus sign icon
As of October 2026, Cytel has approximately 1.6K employees across 6 continents, including North America, Asia and Europe. Key team members include Chief Product Officer: K. T., Chief Financial Officer: B. G. and Chief Human Resources Officer: C. M. Explore Cytel's employee directory with LeadIQ.

What industry does Cytel belong to?

Minus sign iconPlus sign icon
Cytel operates in the Pharmaceutical Manufacturing industry.

What technology does Cytel use?

Minus sign iconPlus sign icon
Cytel's tech stack includes HubSpot Analytics, SAP SuccessFactors, Drupal, CookieYes, Hyperion, SAP, GitLab and Microsoft Sentinel.

What is Cytel's email format?

Minus sign iconPlus sign icon
Cytel's email format typically follows the pattern of First.Last@cytel.com. Find more Cytel email formats with LeadIQ.

How much funding has Cytel raised to date?

Minus sign iconPlus sign icon
As of October 2026, Cytel has raised $2M in funding. The last funding round occurred on Jan 01, 2021.

When was Cytel founded?

Minus sign iconPlus sign icon
Cytel was founded in 1987.
Cytel logo

Cytel

Pharmaceutical ManufacturingMassachusetts, United States1001-5000 Employees

Cytel is a data-science contract research organization that supports pharmaceutical development through analytics and clinical trial software. It uses data-driven insights to guide strategy across drug development and commercialization, with a focus on adaptive trial design, and offers services from innovative trial design to end-to-end biometrics and real-world evidence. Headquartered in Cambridge, Massachusetts, Cytel has a global presence across North America, Europe, and Asia. Its clients are drug developers seeking efficient, evidence-based trial design and analytics to inform regulatory decisions and improve patient outcomes. In 2024, Cytel launched East Horizon, a platform that advances clinical trial design and simulation.

Section iconCompany Overview

Website
cytel.com
Stock Symbol
IDMI
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1987
Employees
1001-5000

Section iconFunding & Financials

  • $2M

    Cytel has raised a total of $2M of funding over 3 rounds. Their latest funding round was raised on Jan 01, 2021 as a Venture Round.

  • $500M - $1B

    Cytel's revenue is estimated to be in the range of $500M - $1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.